NCT02821793Completed
Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer
Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer : PRIORITY Study
Source: ClinicalTrials.gov · Last updated 1 Jul 2025
Brief summary (registry, in English)
The main objective of study is to describe the priorities of elderly patients (70 years and over) undergoing a first medical treatment for cancer, at initiation of treatment and after 3 months of treatment. The main criterion is a prioritization of 4 items per patient from a list of 8 expectations regarding the objectives of their treatment: treatment efficacy, life expectancy, autonomy, daily activities, social activities, heaviness of treatment, toxicity, economics.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 346 (actual)
- First submitted
- 14 Jun 2016
- Start date
- Jan 2016
- Primary completion date
- Jun 2022
- Lead sponsor
- Institut Bergonié
- NCT number
- NCT02821793
What you commit to
- Study type: Observational
- Participants enrolled: 346
- From Jan 2016 to the primary completion date, Jun 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Exclusive surgery treatment.
- Exclusive radiotherapy treatment or in combination with oncological medical treatment (concomitant radio-chemotherapy or radio-hormonotherapy).
- Previous first line of oncological medical treatment in the same indication as the one concerned by the inclusion:
- Neo-adjuvant setting: previous line(s) of neo-adjuvant medical treatment,
- Adjuvant setting: previous line(s) of adjuvant medical treatment,
- Metastatic setting: previous line(s) of metastatic medical treatment,
- Previous or ongoing cancer under treatment at the time of inclusion.
Other illness
- Patient who for psychological, psychiatric, social, family or geographical reasons could not be regularly monitored according to the criteria of the study; patient private of liberty or under guardianship.
Other
- Supportive care without specific medical treatment
- Patient already included in this study
Who the study is looking for
- Male or female:
- Age ≥ 70 years
- Aged 18-69 years (case population)
- ECOG / performance status 0-3 (WHO).
- First line of medical oncology treatment (chemotherapy, targeted therapy, hormone therapy, combination):
- Neo-adjuvant setting,
- Adjuvant setting: previous neo-adjuvant treatment is allowed,
- Metastatic setting: previous neo-adjuvant and/or adjuvant treatment are allowed,
- Solid tumors (breast, colorectal, kidney, lung, prostate, sarcoma, and ovarian) and lymphoma (indolent and aggressive).
- Life expectancy of more than 3 months.
- Patients potentially compliant with the rules of the follow-up study.
- Patients affiliated to a social security scheme.
- Patients who received clear information from the investigator on the study and had not refused to participate.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Bergonie Coordinator of this site? Confirm its status | Bordeaux | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.